Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

Recruiting now

Conditions studied: Papillary Thyroid Cancer

In brief

To evaluate long-term outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma

Key facts

Study ID

NCT06733740

Run by

Chinese PLA General Hospital

People needed

3000

Starts

2024-12-10

Expected to finish

2030-12-31

Last updated by the study team

2025-02-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients age between 18 and 80 year old, both sex
• papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
• the largest diameter ≤2.0 cm
• no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
• follow-up period ≥12 months

You may not qualify if…

• patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy
• history of neck radiation
• coagulation disorder, serious heart, respiratory, liver, or renal failure
• dysfunction of the vocal cord on the opposite side

Where it is running

• Chinese PLA General Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.